Lv1
94 积分 2023-04-10 加入
Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
1个月前
已完结
An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis
1个月前
已完结
Self-Assembling Enveloped Virus-Mimicking Particle for Extrahepatic Targeting mRNA Delivery
1个月前
已完结
CAR-X cell engineering
1个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
2个月前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
2个月前
已完结
RIPTACs: A groundbreaking approach to drug discovery
5个月前
已完结
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
7个月前
已完结
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
7个月前
已完结
Advancements and challenges in CAR T cell therapy in autoimmune diseases
10个月前
已完结
皖公网安备34019202002308
